AMN HEALTHCARE SERVICES INC (AMN)
US0017441017 - Common Stock
Taking everything into account, AMN scores 5 out of 10 in our fundamental rating. AMN was compared to 114 industry peers in the Health Care Providers & Services industry. While AMN has a great profitability rating, there are some minor concerns on its financial health. AMN has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
In the past year AMN was profitable.
In the past year AMN had a positive cash flow from operations.
In the past 5 years AMN has always been profitable.
In the past 5 years AMN always reported a positive cash flow from operatings.
1.2 Ratios
AMN has a Return On Assets of 1.99%. This is in the better half of the industry: AMN outperforms 66.67% of its industry peers.
AMN has a Return On Equity of 5.96%. This is in the better half of the industry: AMN outperforms 69.30% of its industry peers.
With a decent Return On Invested Capital value of 4.59%, AMN is doing good in the industry, outperforming 61.40% of the companies in the same industry.
AMN had an Average Return On Invested Capital over the past 3 years of 17.26%. This is significantly above the industry average of 8.10%.
The 3 year average ROIC (17.26%) for AMN is well above the current ROIC(4.59%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.99% | ||
| ROE | 5.96% | ||
| ROIC | 4.59% |
ROA(3y)11.01%
ROA(5y)8.39%
ROE(3y)32.02%
ROE(5y)24.03%
ROIC(3y)17.26%
ROIC(5y)13.59%
1.3 Margins
The Profit Margin of AMN (1.73%) is better than 67.54% of its industry peers.
AMN's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 4.37%, AMN is doing good in the industry, outperforming 63.16% of the companies in the same industry.
In the last couple of years the Operating Margin of AMN has remained more or less at the same level.
With a Gross Margin value of 31.34%, AMN perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
In the last couple of years the Gross Margin of AMN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.37% | ||
| PM (TTM) | 1.73% | ||
| GM | 31.34% |
OM growth 3Y1.49%
OM growth 5Y-1.21%
PM growth 3Y23.47%
PM growth 5Y-3.47%
GM growth 3Y-0.1%
GM growth 5Y0.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so AMN is creating value.
Compared to 1 year ago, AMN has less shares outstanding
Compared to 5 years ago, AMN has less shares outstanding
Compared to 1 year ago, AMN has a worse debt to assets ratio.
2.2 Solvency
AMN has an Altman-Z score of 2.51. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of AMN (2.51) is better than 63.16% of its industry peers.
The Debt to FCF ratio of AMN is 10.26, which is on the high side as it means it would take AMN, 10.26 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AMN (10.26) is better than 64.91% of its industry peers.
A Debt/Equity ratio of 1.27 is on the high side and indicates that AMN has dependencies on debt financing.
AMN has a Debt to Equity ratio of 1.27. This is in the lower half of the industry: AMN underperforms 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 10.26 | ||
| Altman-Z | 2.51 |
ROIC/WACC0.75
WACC6.15%
2.3 Liquidity
AMN has a Current Ratio of 1.18. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN's Current ratio of 1.18 is on the low side compared to the rest of the industry. AMN is outperformed by 64.91% of its industry peers.
A Quick Ratio of 1.18 indicates that AMN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.18, AMN is in line with its industry, outperforming 42.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.37%.
Measured over the past years, AMN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.92% on average per year.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.12%.
Measured over the past years, AMN shows a quite strong growth in Revenue. The Revenue has been growing by 12.15% on average per year.
EPS 1Y (TTM)-58.37%
EPS 3Y33.37%
EPS 5Y19.92%
EPS Q2Q%-69.04%
Revenue 1Y (TTM)-25.12%
Revenue growth 3Y16.55%
Revenue growth 5Y12.15%
Sales Q2Q%-19.44%
3.2 Future
Based on estimates for the next years, AMN will show a decrease in Earnings Per Share. The EPS will decrease by -0.91% on average per year.
Based on estimates for the next years, AMN will show a decrease in Revenue. The Revenue will decrease by -1.97% on average per year.
EPS Next Y-61.29%
EPS Next 2Y-42.55%
EPS Next 3Y-26.95%
EPS Next 5Y-0.91%
Revenue Next Year-22.83%
Revenue Next 2Y-14.5%
Revenue Next 3Y-8.64%
Revenue Next 5Y-1.97%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 7.16, the valuation of AMN can be described as very cheap.
Based on the Price/Earnings ratio, AMN is valued cheaper than 98.25% of the companies in the same industry.
AMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.38.
Based on the Price/Forward Earnings ratio of 10.32, the valuation of AMN can be described as reasonable.
Based on the Price/Forward Earnings ratio, AMN is valued cheaper than 92.11% of the companies in the same industry.
AMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.16 | ||
| Fwd PE | 10.32 |
4.2 Price Multiples
88.60% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
92.11% of the companies in the same industry are more expensive than AMN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.59 | ||
| EV/EBITDA | 7.12 |
4.3 Compensation for Growth
The decent profitability rating of AMN may justify a higher PE ratio.
A cheap valuation may be justified as AMN's earnings are expected to decrease with -26.95% in the coming years.
PEG (NY)N/A
PEG (5Y)0.36
EPS Next 2Y-42.55%
EPS Next 3Y-26.95%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMN HEALTHCARE SERVICES INC
NYSE:AMN (11/11/2024, 8:20:25 PM)
After market: 27.8 0 (0%)27.8
-1.25 (-4.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.06B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.16 | ||
| Fwd PE | 10.32 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.99% | ||
| ROE | 5.96% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.37% | ||
| PM (TTM) | 1.73% | ||
| GM | 31.34% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-58.37%
EPS 3Y33.37%
EPS 5Y
EPS Q2Q%
EPS Next Y-61.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-25.12%
Revenue growth 3Y16.55%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y